End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.035 CAD | -12.50% | -12.50% | +40.00% |
02-28 | NAVCO Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
Sales 2022 | 58.73K 42.92K 3.42M | Sales 2023 | - | Capitalization | 1.21M 885K 70.51M |
---|---|---|---|---|---|
Net income 2022 | - 0 0 | Net income 2023 | -2M -1.46M -116M | EV / Sales 2022 * | - |
Net Debt 2022 | 896K 655K 52.22M | Net Debt 2023 | 370K 270K 21.54M | EV / Sales 2023 | - |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
-0.42
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99% |
1 day | -12.50% |
1st Jan change | Capi. | |
---|---|---|
+10.32% | 382B | |
+8.96% | 129B | |
-16.24% | 62.7B | |
+0.37% | 52.62B | |
-11.47% | 36.49B | |
+3.35% | 33.44B | |
+9.60% | 17.62B | |
+7.81% | 14.93B | |
-8.87% | 10.76B |
- Stock Market
- Equities
- NAV Stock
- NAV Stock